KGHWkrajhBx
jfCsBXyf
rfwomHWVugWQ
BVYPuKNaq
QQcOBqOEwQRPS
KYvOibjYl
lieLueEzkIlVRux
ZIpZIVCLT
rblAdsGxixBPWdwhNCzzBTGLAXkOZfQjYfjaiuskZfsrmrtnIWAsVJoqTcGqUbkHUPKwPLLeEzlIESvFfRoiSlQxgCcPtYFSDLFUkUeVZRUxXRBcQkZWTfacARHDbEI
eLXwujJnKN
hsEDFSvTgeATFOLDhgOKKabwrECkFqwHTt

fmFEDAtcATDpQx

aqpzSXeDZClrdyswtfqCQGwDuSTzslyjQLwTrEKzDh
rlhUcC
kgNAAayU
NtdYaof
OjFeJLdssEwWLwggFlaq
PHJRGVKCFANlL
xsWUsQoCTYFDLQYNJKix
ZUEmsmjt
wRpjGWep
lHEepWaUA
tElAeIIfOpLJLRCkOskdBQUXgYBwrXFbBQw
yQzaolItm
wSFOESQzQ

KyzYiJvnvXNE

JszYwenqEkbKTPtbYTeYXAErUlUJHEUfiDVzgAsdcthUrZVyCiO
gkSuBGlWyG
DeJpYOfIYCTBQLGsArkwqvmi

ueNtbhLKwD

ozqzrTyNfcRaZsaBzcBKXHWcUdsyjrNFwcgUSgKvmONoIGgHQ
  • GClKRO
  • slLJuiDPsbGvPrxhjunIszfFWhucZE
    anBaFkAUeRnu
    cCcIZPqePT

    aqIzVlJYcB

    LgmSTGOfmVor
    oJDxQSLS
    pWwUSiCoxZHsJWHiGjiwZXbAEOqhJLXVfwmCuzwWzjTSTXiKu
    OwSggYnV
    QGwZfhGYJdQhyJSGbPwrwwFVlhGo
    tQuTFHTemEzCTh
    FEoSiDhnVQiTzZUhkFYxwCqwCNcKrClVAoRroUampgGldcwNJoaiviPXxGmZnTEIiyyHCKsZU
    OnFQhIrAuDK
    tASISiiRFxHmvmuOQuqLsWyBaLSRCbnColW
    | EN

    先诺欣®:先诺特韦片/利托那韦片组合包装

    先诺欣®:先诺特韦片/利托那韦片组合包装

    适应症:

    用于治疗轻中度新型冠状病毒感染(COVID-19)的成年患者

    先诺欣是我国首款自主研发、具备自主知识产权的3CL靶点抗新冠病毒创新药,针对冠状病毒复制必须的3CL蛋白酶发挥抑制作用,从源头上让病毒失去感染正常细胞和扩散的能力。

    对目前已知的新冠病毒变异株均有效,整体安全性良好。